Quarterly sales for Kensey Nash Corp. were essentially flat, compared to the same period last year, and sales fell for its orthopedic and spine line, according to a release from the company.
For its first quarter, which ended on Sept. 30, the company reported that net sales of biomaterials products were $12.6 million, compared to $12.7 million in the comparable period last year.
Orthopedic sales, primarily of sports medicine and spine products, fell from $8.0 million to $6.4 million, and within that figure, net sales of spine products fell $1.0 million to $2.7 million.
Read the release on Kensey Nash’s quarterly sales.
From findings on cervical disc replacement to total knee replacement, Becker’s reported on eight spine and orthopedic studies since March…
Researchers at UMass Chan Medical School in Worcester, Mass., have created an algorithm to predict total knee replacement outcomes in…
Orthopaedic Solutions Management has acquired Orlando Hand Surgical Associates, marking its eighth acquisition. OHSA was founded in 2000 and has…
Comments are closed.